Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cerulean Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cerulean Pharma Inc (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Jul 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for CERU

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

26 Jun 2016 ValuEngine, Inc. 11 $25.00

CERULEAN PHARMA INC (CERU=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

25 Jun 2016 Pechala's Reports 2 $25.00

CERULEAN PHARMA - UPDATE ON OVARIAN CANCER AND CRLX301

Cerulean recently presented the results on the Phase Ib trial of CRLX101 with weekly paclitaxel for the treatment of platinum...

24 Jun 2016 Edison Investment Research 6 $10.00

Wright Investors Service Comprehensive Report for Cerulean Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

22 Jun 2016 Wright Reports 58 $75.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) formerly Tempo Pharmaceutic...

17 Jun 2016 GlobalData 48 $300.00

CERULEAN PHARMA - PHASE II RENAL DATA PUSHED TO Q3 FROM Q2

Cerulean reported first quarter results and provided a pipeline update on 2 May, while confirming an expected cash runway for...

17 May 2016 Edison Investment Research 3 $10.00

Thomson Reuters Stock Report - Cerulean Pharma Inc (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

CERU.OQ - Event Transcript of Cerulean Pharma Inc conference call, May 02, 2016 / 4:30PM ET

Edited Event Transcript of CERU.OQ conference call, May 02, 2016 / 4:30PM ET Boston, May 3, 2016 (Thomson StreetEvents)...

02 May 2016 Thomson Reuters StreetEvents 16 $75.00